EBV p18 Protein (AA 1-119)

Produktnummer ABIN935323

Produktdetails

Target: EBV p18 (EBV VCA p18) (Epstein-Barr Virus Viral Capsid Antigen p18 (EBV VCA p18))

Protein-Typ: Recombinant

Proteineigenschaft: AA 1-119

Spezies: Epstein-Barr Virus (EBV)

Quelle: Escherichia coli (E. coli)

Applikation: ELISA, Western Blotting (WB)

Produktmerkmale: Purified recombinant EBV p18 protein
Expression System: E.coli

Aufreinigung: Proprietary chromatographic technique

Reinheit: > 95 % pure

Anwendungsinformationen

Applikationshinweise: Each Investigator should determine their own optimal working dilution for specific applications.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: 25 mM Tris-HCl, 1.5 M Urea and 50 % Glycerol.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: RT/-20 °C

Antigendetails

Target: EBV p18 (EBV VCA p18) (Epstein-Barr Virus Viral Capsid Antigen p18 (EBV VCA p18))

Andere Bezeichnung: EBV p18 (EBV VCA p18 Produkte)

Substanzklasse: Viral Protein

Hintergrund: The Epstein-Barr virus (EBV), also called Human herpes virus 4 (HHV-4), is a virusof the herpes family (which includes Herpes simplex virusand Cytomegalo virus. On infecting the B-lymphocyte, the linear virus genome circularizes and the virus subsequently persists within the cell as an episome. The virus can execute several distinct programs of gene expressionwhich can be broadly categorized as being lytic cycle or latent cycle. The lytic cycleor productive infection results in staged expression of a host of viral proteinswith the ultimate objective of producing infectious virions. Formally, this phase of infection does not inevitably lead to lysis of the host cellas EBV virions are produced by budding from the infected cell. The latent cycle(lysogenic) programs are those that do not result in production of virions.
Alternative Names: Epstein Barr, EBV HHV4 p18 protein, Epstein-Barr Virus p18 protein